AU2825295A - Method for the treatment, prevention or minimization of hair loss - Google Patents

Method for the treatment, prevention or minimization of hair loss

Info

Publication number
AU2825295A
AU2825295A AU28252/95A AU2825295A AU2825295A AU 2825295 A AU2825295 A AU 2825295A AU 28252/95 A AU28252/95 A AU 28252/95A AU 2825295 A AU2825295 A AU 2825295A AU 2825295 A AU2825295 A AU 2825295A
Authority
AU
Australia
Prior art keywords
minimization
prevention
treatment
hair loss
hair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28252/95A
Inventor
Kenneth A. Arndt
Stephen J. Galli
Maureen H McCaloon
Richard J Sharpe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arcturus Pharmaceutical Corp
Original Assignee
Arcturus Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arcturus Pharmaceutical Corp filed Critical Arcturus Pharmaceutical Corp
Publication of AU2825295A publication Critical patent/AU2825295A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
AU28252/95A 1994-06-13 1995-06-13 Method for the treatment, prevention or minimization of hair loss Abandoned AU2825295A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25875894A 1994-06-13 1994-06-13
US258758 1994-06-13
PCT/US1995/007470 WO1995034303A1 (en) 1994-06-13 1995-06-13 Method for the treatment, prevention or minimization of hair loss

Publications (1)

Publication Number Publication Date
AU2825295A true AU2825295A (en) 1996-01-05

Family

ID=22982010

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28252/95A Abandoned AU2825295A (en) 1994-06-13 1995-06-13 Method for the treatment, prevention or minimization of hair loss

Country Status (2)

Country Link
AU (1) AU2825295A (en)
WO (1) WO1995034303A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU764073B2 (en) * 1997-06-04 2003-08-07 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
EP1083877A1 (en) * 1998-06-03 2001-03-21 GPI NIL Holdings, Inc. N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
CN1604772A (en) * 2001-12-13 2005-04-06 生命健康科学有限公司 Transdermal transport of compounds
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
FR2856592B1 (en) * 2003-06-27 2008-04-25 Oreal A COSMETIC COMPOSITION BASED ON A RADICAL THIYL DRYER (S) FOR THE PERMANENT DEFORMATION OF KERATIN FIBERS
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
KR20080019228A (en) 2005-06-17 2008-03-03 바이탈 헬스 사이언시즈 피티와이 리미티드 A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
WO2011120084A1 (en) 2010-03-30 2011-10-06 Phosphagenics Limited Transdermal delivery patch
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd Amino-quinolines as kinase inhibitors
DK3066089T3 (en) 2013-11-08 2020-01-27 Promentis Pharm Inc SUBSTITUTED N-ACETYL-L-CYSTEIN DERIVATIVES AND RELATED COMPOUNDS
CA3007587C (en) 2015-12-09 2023-12-05 Phosphagenics Limited Pharmaceutical formulation
GB201610910D0 (en) * 2016-06-22 2016-08-03 Paxman Coolers Ltd Composition and apparatus for treatment of chemotherapy induced alopecia
KR102647670B1 (en) 2016-12-21 2024-03-15 아베초 바이오테크놀로지 리미티드 method
WO2019083288A1 (en) * 2017-10-25 2019-05-02 연세대학교 산학협력단 Composition comprising suberic acid as active ingredient for preventing hair loss or stimulating new hair growth

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194117B (en) * 1981-11-20 1988-09-14 Isnardi Pietro & C Spa SALICYL DERIVATIVES OF N-ACETYLCISTEIN
GB8918709D0 (en) * 1989-08-16 1989-09-27 Unilever Plc Cosmetic composition
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy

Also Published As

Publication number Publication date
WO1995034303A1 (en) 1995-12-21

Similar Documents

Publication Publication Date Title
AU3896495A (en) Combination method for acne treatment
AU4119899A (en) System for treating the fundus of an eye
ZA9610249B (en) Treatment of vegetables.
AU1569295A (en) Water treatment process
AU6405198A (en) Plant for the treatment of products, which includes means for characterizing the products
ZA9710322B (en) Process for the preparation of benzyl-ethers.
AUPM761094A0 (en) Treatment of hides
AU2825295A (en) Method for the treatment, prevention or minimization of hair loss
AU5038299A (en) Process for the biocidal treatment of surfaces
AU3616495A (en) Treating pressure vessels
AU8048494A (en) Fluid treatment process
AU7678796A (en) Method for the treatment, prevention or minimization of hair loss using a source of fatty acids
AUPM959994A0 (en) Water treatment process
GR950100091A (en) Method for the treatment of plants.
EP0669361A3 (en) Method for the preparation of polyheterosiloxanes.
ZA974421B (en) Method of improving skin condition.
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU2068295A (en) Skin treatment composition
AU1630895A (en) Treatment of H. pylori infections
AU5699396A (en) Compositions for the treatment of skin conditions
ZA977867B (en) Method of treatment.
EP0682034A3 (en) Process for organooxylation of cyanoalkylchlorosilanes.
AU2966695A (en) Method and compound for the treatment of hair loss
ZA976071B (en) Process for the monoacylation of hydroxytaxanes.
AU3974495A (en) Optical treatment method